 "Fujifilm Diosynth Biotechnologies facility")
Fujifilm Corporation will invest about Yen 14 billion ($ 130 million) for increasing the production capacity in the US and UK to expand the business of its BioCDMO division, which focuses on contract development & manufacturing for biologics.
In the US, at Fujifilm Diosynth Biotechnologies (FDB), has already invested JPY 10 billion ($ 93 million) - a part of which was funded by BARDA (Biomedical Advanced Research and Development Authority), an office of the US Department of Health and Human Services - for setting up a production facility in Texas (USA).
In addition to this, Fujifilm now plans to invest Yen 3
